Fatty fa/fa Zucker rats with a missense mutation in the leptin receptor (OB-R) are obese and infertile with prolonged estrous cycles. To determine whether their reproductive deficits could be corrected by OB-R installation, we employed viral vectors to introduce the OB-R gene into either the arcuate nucleus (ARC) or the paraventricular nucleus (PVN) of the hypothalamus, sites of OB-R expression in wild-type rats. Recombinant adeno-associated viral (rAAV) vectors encoding the human leptin-receptor gene (rAAV-OB-Rb) were microinjected intraparenchymally to produce doxycycline-regulatable OB-R gene expression. Expression of the OB-R gene in the ARC and PVN was verified using reverse transcription-polymerase chain reaction. Expression of OB-R in the ARC, but not in the PVN, resulted in normalization of estrous cycle length, increased ovarian follicular development, and decreased serum progesterone levels. Compared to saline-injected rats, hypothalamic expression of neuropeptide Y (NPY) and pro-opiomelanocortin were decreased in ARC rAAV-OB-Rb-injected rats. Parallel decreases were noted in NPY and ␤-endorphin (␤-END) concentrations in the hypothalamus, whereas luteinizing hormone-releasing hormone (LHRH) levels increased. These studies showed that rAAV vectors can be successfully used to install functional OB-R in the hypothalamus for extended periods. The resultant stimulation of the hypothalamopituitary-gonadal (HPG) axis in ARC-injected rats was probably brought about by the observed decreases in NPY and ␤-END, which inhibit hypothalamic LHRH. Because these changes were seen in ARC-injected, but not in PVN-injected, rats, the results suggest that the ARC may be the primary site where leptin acts to regulate the HPG axis.
INTRODUCTION
Secreted by white adipocytes, leptin is best known for its role in maintaining energy balance by decreasing food intake and increasing energy expenditure [1] [2] [3] [4] . Several reports suggest that leptin also has a role in normal reproductive function. Leptin acts as a permissive signal for the onset of puberty, reverses fasting-induced anestrus and decreases LH in rodents, and counteracts the negative effects of insulin-like growth factor-I on follicular development [5] [6] [7] [8] [9] [10] . Leptin also has been reported to stimulate the release of LH-releasing hormone (LHRH) from the hypothalamus as well as FSH and LH from the pituitary [7, 8, [11] [12] [13] . Conversely, animals with mutations in either the leptin or the leptin-receptor (OB-R) gene have nonfunctional reproductive axes [14, 15] . The homozygous (fa/fa) fatty Zucker rat has a mutated OB-R gene that causes several perturbations in the hypothalamo-pituitary-gonadal (HPG) axis [16] . These rats are infertile, with abnormal estrous cycles, decreased plasma sex steroids, hyporesponsiveness to sexsteroid hormones, and attenuated sexual behavior and LH surge [14, [17] [18] [19] [20] .
The OB-R has been localized to several hypothalamic nuclei, including the ventromedial hypothalamus, the medial preoptic area (MPOA), the paraventricular nucleus (PVN), and the arcuate nucleus (ARC) [21] [22] [23] [24] [25] [26] . The OB-R mRNA colocalizes with neuropeptide Y (NPY) as well as pro-opiomelanocortin (POMC) mRNA-expressing neurons in the ARC, but not with LHRH in the MPOA [10, [27] [28] [29] [30] . Leptin action in the central nervous system inhibits the activity of both NPY and POMC neurons [31] [32] [33] .
In a normal gonadal steroid environment, NPY stimulates the release of LHRH [34] [35] [36] [37] . Production of NPY in the ARC regulates LHRH secretion by action on LHRH perikarya and dendrites in the MPOA and at the level of LHRH nerve terminals in the median eminence [38] . However, a continuous excess of NPY inhibits LHRH secretion, especially under low levels of sex steroids, as present in the fatty Zucker rat [15, 35, [37] [38] [39] . In wild-type rats, leptin inhibits NPY gene expression and stimulates LHRH and LH release [7, 8, [11] [12] [13] ; however, in fatty Zucker rats, NPY expression in the ARC is upregulated as a consequence of defective leptin signaling [40] [41] [42] [43] [44] . Additionally, NPY stimulates the endogenous opioid peptide ␤-endorphin (␤-END), which has a tonic inhibitory influence on both LHRH and LH release [39, 45, 46] . Thus, by restoring normal leptin signaling in fa/fa rats, it might be possible to correct the alterations in neuropeptides contributing to the reproductive dysfunction in the female fatty Zucker rat.
Recombinant adeno-associated viral (rAAV) vectors are derived from a single-stranded DNA parvovirus that integrates into the host's genome with little, if any, immunogenicity. It has good transduction efficiency in nondividing cells and selectively infects neurons in the brain for longterm, stable transgene expression [47] [48] [49] [50] [51] . To our knowledge, the only drawback in using rAAV is its relatively small insert size (4.7 kilobases). We have used rAAV successfully to transfer the leptin gene into the rodent brain A) The rAAV-OB-Rb vector encoding the human leptin-receptor gene with a polyadenylated tail (Poly-A) sequence driven by a tetracycline-responsive promoter and flanked by inverted terminal repeats (TR). B) The rAAV-rtTA/rTS vector encoding the regulatory sequences, rtTA and rTS, separated by an internal ribosomal entry site (IRES) sequence, with a Poly-A sequence flanked by terminal repeats and driven by the chicken ␤-actin promoter with a cytomegalovirus (CMV) enhancer. [52, 53] . In the present study, we used rAAV to transfer the OB-R gene into the hypothalamus of female fatty Zucker rats, and we determined its effects on the HPG axis.
MATERIALS AND METHODS

Viral Vectors
The two vectors used in the present study are shown in Figure 1 . One rAAV transfer vector carried the transgene under the control of a tetracycline-responsive promoter (tetO). The second vector is a combination of a transcriptional activator and repressor driven by the strong housekeeping promoter, chicken ␤-actin promoter (CBA), with a cytomegalovirus enhancer to provide control over expression of the transgene using a tetracycline-like compound, doxycycline (dox). To construct the receptor vector, designated rAAV-OB-Rb, the human long-form OB-R cDNA, cloned from pCDNA3.1-OB-Rb (a gift from Dr. H. Hsiung, Lilly Research Laboratories, Indianapolis, IN) was subcloned into pTR-UF13 plasmid vector downstream of tetO. The promoter vector, designated rAAV-rtTA/ rTS, was constructed to encode two chimeric genes, a reverse tet-regulatable trans-activator (rtTA), which activates gene transcription in the presence of dox, and a tet-controlled trans-repressor (tTS), which silences gene expression in the absence of dox. Expression of both genes is linked by an internal ribosomal entry site into one di-cistronic cassette with a CBA, which is active in all cell types, including neurons. In the absence of dox, the tTS protein product forms a homodimer, binds to tetO, and prevents unregulated gene transcription. However, in the presence of dox, the rtTA protein product undergoes a conformational change, forms a homodimer, and binds to tetO to initiate gene transcription of OB-R. Both vectors, rAAV-OB-Rb and rAAV-rtTA/tTS, were packaged and titered at the University of Florida Powell Gene Therapy Center as previously described [52, 53] .
Animals
All animal procedures were approved by the Institutional Animal Care and Use Committee at the University of Florida. Female fatty (fa/fa) Zucker rats (age, 3-4 wk) were purchased from Harlan Sprague-Dawley (Indianapolis, IN) and housed in individual cages in air-conditioned rooms (22ЊC) with lights-on from 0500 to 1900 h. Rat chow (Ralston Purina Co., St. Louis, MO) and tap water were available ad libitum. Under ketamine/ xylazine anesthesia (ketamine, 100 mg/kg body weight [BW]; xylazine, 15 mg/kg BW), rats were fitted into a stereotaxic apparatus. With the aid of a Kopf microinjector, four rats were microinjected with 1 l of saline, and 12 rats were microinjected with 0.5 l of rAAV-OB-Rb (2.4 ϫ 10 10 infectious particles/ml) plus 0.5 l of rAAV-rTS/rtTA (4.5 ϫ 10 9 particles/ ml) bilaterally into the ARC (2.7 mm posterior to bregma, 0.2 mm lateral of the sagittal sinus, and 9.8 mm ventral to the dura mater). Seven rats were microinjected with 0.5 l of rAAV-OB-Rb (2.4 ϫ 10 10 infectious particles/ml) plus 0.5 l of rAAV-rTS/rtTA (4.5 ϫ 10 9 particles/ml) bilaterally into the PVN (1.8 mm posterior to bregma, 0.4 mm lateral of the sagittal sinus, and 7.5 mm ventral to the dura mater) [54] . Rats were allowed 7-10 days to recover from surgery. Half the rats microinjected with rAAV-OB-Rb in the ARC and all the rats injected with saline or rAAV-OB-Rb in the PVN were provided dox (Clontech, Palo Alto, CA) at 250 mg/L in 0.1% saccharin drinking water. The other half of the group microinjected with rAAV-OB-Rb in the ARC were given drinking water containing 0.1% saccharin during the 60-day experiment. Estrous cycles were monitored by daily examination of vaginal cytology.
Approximately 60 days after the start of the dox treatment, rats in diestrus were killed in the morning by decapitation. The brains were rapidly removed, and the hypothalami were excised. The hypothalamic fragment extended from the optic chiasm rostrally to the mammillary bodies caudally and to the lateral sulci. The hypothalamic fragment was divided longitudinally into halves. One half was homogenized in 0.1 N hydrochloric acid and stored at Ϫ20ЊC for peptide analyses. The other half was snap-frozen on dry ice for mRNA quantitation. In addition, ovaries were removed at the time of death and then weighed and processed for histological evaluation of the numbers of corpora lutea, small follicles (diameter, Ͻ300 m), and large follicles (diameter, Ͼ300 m). Serum from trunk blood was collected and stored at Ϫ20ЊC until analysis of estradiol and progesterone.
Reverse Transcription-Polymerase Chain Reaction for OB-R mRNA Expression
Total hypothalamic RNA was extracted and DNase-treated using the RNeasy Kit (Qiagen, Chatsworth, CA) according to the manufacturer's instructions. Primers for the human OB-R were designed using the sequence of the plasmid pCDNA3.1ϩhOBR (Lilly Research Laboratories) to generate a 580-base pair product. The OB-R primers were as follows: sense, 5Ј ATG AGG ACG AAA GCC AGA G; antisense, 5Ј TGT GAG CAA CTG TCC TGG. The gene was amplified using reagents from Perkin-Elmer Biosystems (Foster City, CA) from a single reverse-transcription (RT) reaction with the following parameters: denaturation, 95ЊC for 1 min; annealing, 65ЊC for 1 min; extension, 72ЊC for 1 min; 38 cycles. All samples also underwent polymerase chain reaction (PCR) for an internal cyclophillin control and were quantified as previously described [50, 51] .
Hypothalamic Peptide Estimation
The acidified hypothalamic samples were neutralized with 0.1 N NaOH, and protein concentration was determined using a Bradford protein assay (Bio-Rad, Richmond, CA). Hypothalamic neuropeptide levels were expressed as pg/g protein.
Levels of LHRH in the hypothalamus were measured by RIA according to the method previously described by Bonavera et al. [55] using synthetic LHRH (Peninsula Laboratories, Belmont, CA) as both reference standard and iodinated hormone. The LHRH antiserum (EL-14) was obtained from Drs. W.E. Ellinwood and M. Kelly (Oregon Regional Primate Center, Portland, OR). All 50-l samples were processed in the same assay, and the sensitivity of the assay was 0.2 pg/tube.
The concentration of NPY in the hypothalamus was determined by RIA as described previously [56] using porcine NPY as the reference standard (Peninsula Laboratories). Antiserum to NPY (RA31) was originally supplied by Dr. William Crowley (University of Tennessee, Memphis, TN). Iodinated NPY was purchased from Amersham Corporation (Arlington Heights, IL). All 50-l samples were processed in the same assay, and the sensitivity of the assay was 1.95 pg/tube. Levels of ␤-END were measured by the RIA procedure described by Koenig et al. [57] . The antiserum (#BN-3) was obtained from Dr. L. Krulich (University of Texas, Dallas, TX). The ␤-END (Peninsula Laboratories) was used as both standard and iodinated hormone. All 50-l samples were processed in the same assay, and the sensitivity of the assay was 2.5 pg/tube.
Serum Steroid Measurements
Serum estradiol was measured in samples extracted with diethyl ether using the third-generation estradiol RIA kit from Diagnostic Systems Laboratories (Webster, TX) according to the manufacturer's instructions. The sensitivity of the assay was 0.6 pg/ml, and all samples were processed in the same assay.
Serum progesterone was measured in nonextracted samples using a kit from Diagnostic Systems Laboratories according to the manufacturer's instructions. The sensitivity of the assay was 0.10 ng/ml, and all samples were processed in the same assay.
Quantitative PCR
Total hypothalamic RNA was extracted and DNase-treated using RNeasy Kit (Qiagen). One microgram of RNA was reverse-transcribed using random hexamer primer Taqman reagents (PE Applied Biosystems, Foster City, CA) according to the manufacturer's instructions. Synthesized cDNA corresponding to 50 ng of total RNA was used for real-time quantitative PCR.
Gene-specific primers and probes were designed for POMC and NPY using Primer Express Software (PE Applied Biosystems) according to the manufacturer's guidelines. All primers and Taqman probes were purchased from PE Applied Biosystems. Taqman PCR assays for both genes were performed on cDNA samples in 96-well plates on an ABI Prism 7000 Sequence Detection System (PE Applied Biosystems). The 18S assays, designed and purchased through PE Applied Biosystems, were run in parallel to each different sample. Each 25-l reaction involved 12.5 l of Taqman 2ϫ Master Mix (PE Applied Biosystems), 1.0 l of cDNA, 2.5 l of sense primer (8 M), 2.5 l of antisense primer (8 M), 0.3 l of probe (100 nM), and 6.2 l of PCR-grade water. The PCR parameters were 95ЊC for 10 min followed by 40 cycles of 60ЊC for 1 min and 95Њ C for 15 sec. The gene-specific primers were as follows: POMC: sense, 5Ј GGC CTT TCC CCT AGA GTT CAA; antisense, 5Ј ACG TGC TCC AAG CCA TCA G POMC probe: 6FAMAGC TGG AAG GCG AGCMGBNFQ NPY: sense, 5Ј AAC CAG TCT GCC TGT CCC AC; antisense, 5Ј CAA GGG AAA TGG GTC GGA NPY probe: 6FAMATG CAT GCC ACC AGG CTG GTAMRA
Statistical Analysis
All values are expressed as the mean Ϯ SEM. Statistical analyses were performed by one-way ANOVA followed by the Tukey post-hoc test using GraphPad Prism software (GraphPad Software, San Diego, CA). The level of significance was set at P Ͻ 0.05 for all analyses. For the real-time quantitative PCR data, statistics were done on values normalized to 18S before the data were transformed into percentage differences.
RESULTS
Expression of OB-R mRNA in hypothalami was assessed by RT-PCR as shown in Figure 2 . As expected, no OB-R mRNA was detectable in control rats injected with saline. However, significant expression of human OB-R mRNA was detected in rats microinjected with rAAV-OBRb in the ARC or PVN and provided dox in the drinking water. Surprisingly, we also detected some expression of OB-R mRNA in rAAV-OB-Rb-injected rats that were not given dox. This expression, however, was only a fraction of that seen in rats given both vectors along with dox ( Fig.  2A) .
The effects of rAAV-OB-Rb on reproductive function are shown in Table 1 . In control, saline-injected rats, estrous cycle length averaged 7.8 Ϯ 0.8 days, with several prolonged periods of diestrus (predominantly leukocytic vaginal cytology) ranging from 8 to 20 days. This was essentially unchanged in rats given either of the vectors in the ARC without dox (7.4 Ϯ 0.4 days) or when the vectors were microinjected in the PVN (6.6 Ϯ 0.4 days). However, rats injected with rAAV-OB-Rb in the ARC and given dox showed significantly shorter estrous cycle lengths (4.7 Ϯ 0.4 days, P Ͻ 0.05) as well as increased incidence of vaginal estrus (cornified cells) exhibited over the 60-day period of the experiment. Furthermore, ovarian weights were significantly higher in ARC-injected rats. However, uterine weights were significantly reduced in these rats as well as in those not given dox. The BW was measured at the beginning and end of the study, and only rats given rAAV-OB-Rb with dox in the ARC had significantly reduced BW compared to the saline group (388 Ϯ 12 vs. 461 Ϯ 28 g, P Ͻ 0.05).
Representative hematoxylin and eosin-stained ovarian sections of rats given saline or the vectors with dox are shown in Figure 3 , A and B. The quantified effect of rAAV-OB-Rb on follicular development and on the number of corpora lutea is listed in Table 1 . The ovaries of salineinjected rats and of vector-treated rats not given dox contained mostly corpora lutea and a few small follicles. Large antral follicles were rarely seen. In contrast, the ovaries of rats treated with rAAV-OB-Rb plus dox contained both normal corpora lutea and follicles at various stages of development, including large antral follicles. Expression of rAAV-OB-Rb in the ARC significantly decreased the number of corpora lutea (P Ͻ 0.05) and increased the number of both large and small follicles per ovary. The number of small follicles (diameter, Ͻ300 m) was doubled, and several large antral follicles (diameters, Ͼ300 m) were observed. Some evidence of ovarian follicular development was also seen in ARC-injected rats not provided dox.
Serum estradiol and progesterone levels are also shown in Table 1 . Estradiol levels were relatively low in fatty Zucker rats, and no effect of viral vector treatment on serum estradiol levels measured at diestrus was found. The control groups of rats had elevated serum progesterone levels characteristic of diestrus; however, rats microinjected in the ARC had significantly lower progesterone levels, regardless of dox treatment. No effect of rAAV-OB-Rb microinjection into the PVN was observed on any parameter of reproductive function ( Table 1) .
The effect of rAAV-OB-Rb on LHRH concentration in the hypothalamus is shown in Figure 4 . Expression of rAAV-OB-Rb in the ARC significantly elevated hypothalamic LHRH peptide levels in the female fatty Zucker rats. In control rats injected with saline, the LHRH concentration was 1. (10.2 Ϯ 1.7 vs. 29.9 Ϯ 4.7 pg/g protein in saline-injected rats, P Ͻ 0.05) (Fig. 5B) . No change was observed in NPY mRNA expression in rats given the vectors without dox or given the vectors with dox in the PVN; however, a small decrease in NPY concentration in ARC-injected rats without dox (19.3 Ϯ 2.4 pg/g protein) was noted.
Expression of POMC mRNA was markedly reduced in rats injected with rAAV-OB-Rb (Fig. 6) . However, only the rats given rAAV-OB-Rb with dox in the ARC had significantly decreased hypothalamic ␤-END levels compared to all other treatment groups, regardless of dox treatment. As shown in Figure 6B , ␤-END levels were significantly reduced in ARC-injected rats given dox compared to salineinjected rats. However, no difference was observed in ␤-END levels of ARC-injected rats not given dox or PVNinjected rats compared to the saline-treated rats.
DISCUSSION
The present study demonstrates, to our knowledge for the first time, the feasibility of using rAAV vectors to sitespecifically express functional OB-R in the hypothalami of female fatty Zucker rats for extended periods. The vector system used to install OB-R in the hypothalamus was designed to be regulatable using a tetracycline-like antibiotic, dox. However, RT-PCR analysis of hypothalamic tissue showed that some gene transcription occurred with this system even in the absence of dox. Several explanations are possible for this unexpected outcome, which has been observed in other studies as well [58, 59] . Residual affinity of the rtTA for tetO is possible even in the absence of dox [58] . It has also been shown that the terminal repeats necessary for AAV vector packaging can mediate gene expression [58] . Alternatively, some cells in the ARC could have been transduced only by the rAAV-OB-Rb vector and not by the promoter vector, causing gene expression to occur without regulation. Although we discovered a partial inability to regulate gene expression during the present study in rats given the vector without dox, rats that were given both the vector and dox showed significantly higher levels of OB-R expression.
A plethora of studies have shown that leptin signaling in the hypothalamus is crucial for normal function of the HPG axis [5-8, 10-13, 60-62] . The OB-R has been found in several nuclei in the hypothalamus [21] [22] [23] [24] 26] ; however, to our knowledge, the target site specific for leptin's effects on the HPG axis has yet to be conclusively identified. In the present study, many significant improvements were observed in the HPG axis of rats expressing OB-R in the ARC, whereas OB-R expression in the PVN was virtually without effect on function of the HPG axis.
In the female fatty Zucker rats lacking a functional OB-R, estrous cycles are irregular, with long periods of diestrus [19, 20] . The presence of several corpora lutea in the ovaries verified this observation. In rats with OB-R expression in the ARC, but not in the PVN, estrous cycle length was normalized, and a decrease in the number of corpora lutea was observed. These rats also showed evidence of follicular activity, indicated by a large number of ovarian follicles at various stages of development. Additionally, the ovaries contained corpora lutea, suggesting that the rAAV-OB-Rbtreated rats were, in fact, ovulating. Based on the observed changes in ovarian function, it is reasonable to assume that serum LH and FSH levels were increased. This was supported by the observed increase in hypothalamic LHRH concentration. Our results indicate that functional OB-R in the ARC is both necessary and sufficient to produce normal estrous cycles in the female fatty Zucker rat, especially considering that OB-R installation in the PVN had no such effect. Leptin receptors have also been localized in both the pituitary and the ovary, and leptin can have direct effects on these tissues [63] . Therefore, to restore fertility, we may need to install OB-R at other sites in the HPG axis.
The literature contains conflicting reports about the status of the uterus in the fatty Zucker rat. The initial description of the Zucker rat [14] reported underdeveloped uteri, whereas in 1986, Chelich and Edmonds [64] reported that the uteri appear to be more normal than once thought. In the present study, we observed a decrease in uterine weight in response to OB-R installation in the ARC. Prolonged periods of diestrus suggest that the fatty Zucker rats undergo periods of pseudopregnancy characterized by high progesterone levels and enlarged uteri. Installation of the OB-R in the ARC, but not in the PVN, normalized the estrous cycle length and reduced the number of days in diestrus as well as the number of corpora lutea in the ovary. The resultant reduction in serum progesterone levels and, possibly, endometrial proliferation would explain the observed reduction in uterine weight. Similarly, reductions in progesterone levels and uterine weight were also seen, although to a smaller extent, in the ARC-injected rats without dox that showed partial expression of OB-R.
Leptin receptors have been localized to many nuclei in the brain, but to our knowledge, they have not been colocalized with LHRH neurons in the rat [24, 26, 29, 32, 65, 66] . Therefore, other neuropeptides in the hypothalamus may function as interneurons to signal leptin's effects to LHRH neurons in the MPOA. One candidate, NPY, has bimodal effects on the HPG axis depending on the steroidal state of the animal [38] . In a normal steroid environment, NPY is stimulatory to the HPG axis, causing increases in LHRH and LH; however, in the fatty Zucker rat, in which high NPY levels continuously stimulate NPY receptors, it 271 EFFECTS OF rAAV-OB-Rb IN FEMALE FATTY ZUCKER RATS is inhibitory to LHRH release [35] . Another neuropeptide that inhibits LHRH secretion is ␤-END, a product of the POMC gene [46] . It would follow that decreasing these two neuropeptides in the hypothalamus might stimulate the reproductive axis in these rats. Indeed, we found that functional leptin signaling in the ARC, but not in the PVN, reduced these inhibitory neuropeptides and that removal of this inhibition resulted in upregulation of LHRH. These results support the recent report that functional leptin signaling in the ARC of OB-R-deficient Koletsky rats reduced NPY mRNA expression [67] . Clearly, the ARC NPY perikaryon is the site where leptin acts to decrease NPY gene expression and, thereby, to decrease the supply of NPY at terminals in the MPOA where they are linked to LHRH neurons and also to LHRH terminals in the median eminence, where LHRH is stored before release into the hypophysial portal veins.
Although Morton et al. [67] reported enhanced expression of POMC and, presumably, its protein products following transfer of the OB-R gene into the ARC of Koletsky rats, we observed a decrease in POMC mRNA as well as ␤-END concentration in fatty Zucker rats. This discrepancy in the effects on POMC mRNA may have resulted from the shorter time course of effectiveness when adenovirus was used for gene transfer [67] , in contrast to the longerlasting effectiveness of AAVs (present study). The decrease in hypothalamic ␤-END levels likely reduces the tonic inhibition of LHRH by endogenous opioid peptides and contributes to the observed increase in LHRH levels.
In summary, using viral vector gene therapy, we have successfully expressed the OB-R in the hypothalami of fatty Zucker rats that lack functional OB-R. That this receptor was functional is evidenced by normalization of estrous cycles and ovarian activity. We also observed decreases in hypothalamic NPY and ␤-END peptide levels as well as in their gene expression. These neuropeptidergic changes may be responsible for the observed increase in LHRH levels resulting in activation of the HPG axis. While it remains necessary to examine other nuclei shown to express OB-R in the hypothalamus to identify other target sites involved in leptin's effects on the HPG axis, it would appear that the ARC is the major site of leptin's actions on the HPG axis.
